Gene Therapy Market - Company Profile (Novartis, Kite Pharma, Inc., GlaxoSmithKline PLC, Spark Therapeutics Inc., Bluebird bio Inc., Genethon, Transgene SA, Applied Genetic Technologies Corporation, Oxford BioMedica, and NewLink Genetics Corp.)and Competitive intelligence report 2017

TOC

Chapter: 1 COMPANY PROFILE

1.1. ADAPTIMMUNE THERAPEUTICS PLC.

1.1.1. Company overview

1.1.2. Company snapshot

1.1.3. Operating business segments

1.1.4. Product portfolio

1.1.5. Business performance

1.1.6. Key strategic moves and developments

1.2. BIOCANCELL LTD.

1.2.1. Company overview

1.2.2. Company snapshot

1.2.3. Operating business segments

1.2.4. Product portfolio

1.3. BLUEBIRD BIO, INC.

1.3.1. Company overview

1.3.2. Company snapshot

1.3.3. Operating business segments

1.3.4. Business performance

1.3.5. Key strategic moves and developments

1.4. CELGENE CORPORATION

1.4.1. Company overview

1.4.2. Company snapshot

1.4.3. Operating business segments

1.4.4. Business performance

1.4.5. Key strategic moves and developments

1.5. GILEAD SCIENCES, INC.

1.5.1. Company overview

1.5.2. Company snapshot

1.5.3. Operating business segments

1.5.4. Product portfolio

1.5.5. Business performance

1.5.6. Key strategic moves and developments

1.6. GLAXOSMITHKLINE PLC

1.6.1. Company overview

1.6.2. Company snapshot

1.6.3. Operating business segments

1.6.4. Product portfolio

1.6.5. Business performance

1.6.6. Key strategic moves and developments

1.7. MERCK & CO., INC.

1.7.1. Company overview

1.7.2. Company snapshot

1.7.3. Operating business segments

1.7.4. Product portfolio

1.7.5. Business performance

1.7.6. Key strategic moves and developments

1.8. NOVARTIS AG

1.8.1. Company overview

1.8.2. Company snapshot

1.8.3. Operating business segments

1.8.4. Product portfolio

1.8.5. Business performance

1.8.6. Key strategic moves and developments

1.9. ONCOGENEX PHARMACEUTICALS, INC.

1.9.1. Company overview

1.9.2. Company snapshot

1.9.3. Operating business segments

1.9.4. Business performance

1.9.5. Key strategic moves and developments

1.10. SPARK THERAPEUTICS, INC.

1.10.1. Company overview

1.10.2. Company snapshot

1.10.3. Operating business segments

1.10.4. Product portfolio

1.10.5. Business performance

1.10.6. Key strategic moves and developments

1.11. ABEONA THERAPEUTICS INC.

1.11.1. Company overview

1.11.2. Company snapshot

1.11.3. Operating business segments

1.11.4. Product portfolio

1.11.5. Business performance

1.11.6. Key strategic moves and developments

1.12. ADVERUM BIOTECHNOLOGIES, INC.

1.12.1. Company overview

1.12.2. Company snapshot

1.12.3. Operating business segments

1.12.4. Product portfolio

1.12.5. Key strategic moves and developments

1.13. APPLIED GENETIC TECHNOLOGIES CORPORATION

1.13.1. Company overview

1.13.2. Company snapshot

1.13.3. Operating business segments

1.13.4. Product portfolio

1.13.5. Key strategic moves and developments

1.14. ARBUTUS BIOPHARMA CORPORATION

1.14.1. Company overview

1.14.2. Company snapshot

1.14.3. Product portfolio

1.14.4. Business performance

1.14.5. Key strategic moves and developments

1.15. AUDENTES THERAPEUTICS INC.

1.15.1. Company overview

1.15.2. ompany snapshot

1.15.3. Product portfolio

1.15.4. Key strategic moves and developments

1.16. AVEXIS INC.

1.16.1. Company overview

1.16.2. Company snapshot

1.16.3. Product portfolio

1.16.4. Key strategic moves and developments

1.17. BLUEBIRD BIO, INC.

1.17.1. Company overview

1.17.2. Company snapshot

1.17.3. Operating business segments

1.17.4. Product portfolio

1.17.5. Business performance

1.17.6. Key strategic moves and developments

1.11. CRISPR THERAPEUTICS AG

1.11.1. Company overview

1.11.2. Company snapshot

1.11.3. Product portfolio

1.11.4. Key strategic moves and developments

1.19. EDITAS MEDICINE, INC.

1.19.1. Company overview

1.19.2. Company snapshot

1.19.3. Product portfolio

1.20. INTELLIA THERAPEUTICS INC.

1.20.1. Company overview

1.20.2. Company snapshot

1.20.3. Product portfolio

1.20.4. Business performance

1.21. GILEAD SCIENCES, INC. (KITE PHARMA, INC.)

1.21.1. Company overview

1.21.2. Company snapshot

1.21.3. Operating business segments

1.21.4. Product portfolio

1.21.5. Business performance

1.21.6. Key strategic moves and developments

1.22. REGENXBIO, INC.

1.22.1. Company overview

1.22.2. Company snapshot

1.22.3. Product portfolio

1.22.4. Key strategic moves and developments

1.23. SANGAMO THERAPEUTICS, INC.

1.23.1. Company overview

1.23.2. Company snapshot

1.23.3. Operating business segments

1.23.4. Product portfolio

1.23.5. Business performance

1.23.6. Key strategic moves and developments

1.24. UNIQURE N. V.

1.24.1. Company overview

1.24.2. Company snapshot

1.24.3. Operation segments

1.24.4. Product portfolio

1.24.5. Business performance

1.24.6. Key strategic moves and developments

1.25. VOYAGER THERAPEUTICS, INC.

1.25.1. Company overview

1.25.2. Company snapshot

1.25.3. Operating business segments

1.25.4. Product portfolio

1.25.5. Key strategic moves and developments

LIST OF TABLES AND FIGURES

TABLE 1. ADAPTIMMUNE THERAPEUTICS PLC.: COMPANY SNAPSHOT

TABLE 2. ADAPTIMMUNE THERAPEUTICS PLC.: BUSINESS UNIT

TABLE 3. ADAPTIMMUNE THERAPEUTICS PLC.: PRODUCT PORTFOLIO

TABLE 4. BIOCANCELL LTD.: COMPANY SNAPSHOT

TABLE 5. BIOCANCELL LTD.: PRODUCT CATEGORY

TABLE 6. BIOCANCELL LTD.: PRODUCT PORTFOLIO

TABLE 7. BLUEBIRD BIO, INC.: COMPANY SNAPSHOT

TABLE 8. BLUEBIRD BIO, INC.: PRODUCT CATEGORY

TABLE 9. CELGENE CORPORATION: COMPANY SNAPSHOT

TABLE 10. CELGENE CORPORATION: OPERATING SEGMENTS

TABLE 11. GILEAD SCIENCES, INC.: COMPANY SNAPSHOT

TABLE 12. GILEAD SCIENCES, INC.: OPERATING SEGMENTS

TABLE 13. GILEAD SCIENCES, INC.: PRODUCT PORTFOLIO

TABLE 14. GLAXOSMITHKLINE PLC.: COMPANY SNAPSHOT

TABLE 15. GLAXOSMITHKLINE PLC: OPERATING SEGMENTS

TABLE 16. GLAXOSMITHKLINE PLC: PRODUCT PORTFOLIO

TABLE 17. MERCK & CO., INC.: COMPANY SNAPSHOT

TABLE 18. MERCK & CO., INC.: OPERATING SEGMENTS

TABLE 19. MERCK & CO., INC.: PRODUCT PORTFOLIO

TABLE 20. NOVARTIS AG: COMPANY SNAPSHOT

TABLE 21. NOVARTIS AG : OPERATING DIVISION

TABLE 22. NOVARTIS AG : PRODUCT PORTFOLIO

TABLE 23.. ONCOGENEX PHARMACEUTICALS, INC.: COMPANY SNAPSHOT

TABLE 24. ONCOGENEX PHARMACEUTICALS, INC.: OPERATING SEGMENTS

TABLE 25. SPARK THERAPEUTICS, INC.: COMPANY SNAPSHOT

TABLE 26. SPARK THERAPEUTICS, INC.: PRODUCT CATEGORY

TABLE 27. SPARK THERAPEUTICS, INC.: PRODUCT PORTFOLIO

TABLE 28. ABEONA THERAPEUTICS INC.: COMPANY SNAPSHOT

TABLE 29. ABEONA THERAPEUTICS INC.: PRODUCT CATEGORY

TABLE 30. ABEONA THERAPEUTICS INC.: PRODUCT PORTFOLIO

TABLE 31. ADVERUM BIOTECHNOLOGIES, INC.: COMPANY SNAPSHOT

TABLE 32. ADVERUM BIOTECHNOLOGIES, INC.: PRODUCT CATEGORY

TABLE 33. ADVERUM BIOTECHNOLOGIES, INC.: PRODUCT PORTFOLIO

TABLE 34. APPLIED GENETIC TECHNOLOGIES CORPORATION: COMPANY SNAPSHOT

TABLE 35. APPLIED GENETIC TECHNOLOGIES CORPORATION: OPERATING SEGMENTS

TABLE 36. APPLIED GENETIC TECHNOLOGIES CORPORATION: PRODUCT PORTFOLIO

TABLE 37. ARBUTUS: COMPANY SNAPSHOT

TABLE 38. ARBUTUS: PRODUCT PORTFOLIO

TABLE 39. AUDENTES: COMPANY SNAPSHOT

TABLE 40. AUDENTES: PRODUCT PORTFOLIO

TABLE 41. AVEXIS: COMPANY SNAPSHOT

TABLE 42. AVEXIS: PRODUCT PORTFOLIO

TABLE 43. BLUEBIRD BIO, INC.: COMPANY SNAPSHOT

TABLE 44. BLUEBIRD BIO, INC.: PRODUCT CATEGORY

TABLE 45. BLUEBIRD BIO, INC.: PRODUCT PORTFOLIO

TABLE 46. CRISPR: COMPANY SNAPSHOT

TABLE 47. CRISPR: PRODUCT PORTFOLIO

TABLE 48. EDITAS MEDICINE, INC.: COMPANY SNAPSHOT

TABLE 49. EDITAS MEDICINE: PRODUCT PORTFOLIO

TABLE 50. INTELLIA THERAPEUTICS: COMPANY SNAPSHOT

TABLE 51. INTELLIA THERAPEUTICS: PRODUCT PORTFOLIO

TABLE 52. GILEAD: COMPANY SNAPSHOT

TABLE 53.. GILEAD SCIENCES, INC.: OPERATING SEGMENTS

TABLE 54. GILEAD SCIENCES, INC.: PRODUCT PORTFOLIO

TABLE 55. REGENXBIO INC.: COMPANY SNAPSHOT

TABLE 56. REGENXBIO INC.: PRODUCT PORTFOLIO

TABLE 57. SANGAMO THERAPEUTICS, INC. : COMPANY SNAPSHOT

TABLE 58. SANGAMO THERAPEUTICS, INC.: OPERATING SEGMENTS

TABLE 59. SANGAMO THERAPEUTICS, INC.: PRODUCT PORTFOLIO

TABLE 60. UNIQURE N. V.: COMPANY SNAPSHOT

TABLE 61. UNIQURE N. V.: PRODUCT PORTFOLIO

TABLE 62 UNIQURE N. V.: PRODUCT PORTFOLIO

TABLE 63. VOYAGER THERAPEUTICS, INC.: COMPANY SNAPSHOT

TABLE 64. VOYAGER THERAPEUTICS, INC.: PRODUCT CATEGORIES

TABLE 65. VOYAGER THERAPEUTICS, INC.: PRODUCT PORTFOLIO